In Mar 2016, Huarui SmartLink completed an investment in USA Healthcare ETF Allocation Portfolio through an ETF Allocation transaction, with committed capital of USD 25M. The asset is currently valued at USD 82M (2025 Market Value), and has become one of the firm's key tracked opportunities within its global multi-asset allocation framework.

US healthcare services, medtech, and biotech offered clear long-term growth, while ETFs provided diversified and liquid exposure. Based on its assessment of industry trends, valuation levels, and market liquidity, the team continues to deepen research coverage and post-investment monitoring around this opportunity.

The portfolio has been rebalanced and partially monetized multiple times from 2017 to 2024, and is now retained only as a small low-volatility core allocation. In parallel, the investment also raises exposure to healthcare innovation and public health services while preserving diversification and governance transparency. This remains consistent with Huarui SmartLink's investment approach centered on long-term thinking, balanced risk-adjusted returns, and sustainable value creation.